Challenges and opportunities in computational studies for lipid nanoparticle development
Lipid nanoparticles (LNPs) are essential carriers for genetic medicines, yet optimizing their design remains challenging due to numerous parameters. Computational methods—including molecular dynamics (MD), computational fluid dynamics (CFD), and machine learning (ML)—offer molecular insights and predictive power. This perspective highlights recent advances, ongoing challenges, and the need for multiscale modeling frameworks and standardized experimental datasets to systematically explore LNP design space and improve the efficacy of next-generation formulations.
Authors
- Scott P. Brown (ORCID: https://orcid.org/0000-0003-2797-5409)
- Sean K. Bedingfield
- Arezoo M. Ardekani (ORCID: https://orcid.org/0000-0003-3301-3193)
- Severin T. Schneebeli (ORCID: https://orcid.org/0000-0002-9511-9922)
- Younghoon Oh (ORCID: https://orcid.org/0000-0003-2454-1701)
- Jianing Li (ORCID: https://orcid.org/0000-0002-0143-8894)
- Kyle J. Colston
Institutions
- Eli Lilly (United States) (US)
- Purdue University West Lafayette (US)
Publication Details
- Journal
- npj Drug Discovery.
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1038/s44386-025-00024-3
- Citations
- 4
- Primary Topic
- Lipid Membrane Structure and Behavior
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- Eli Lilly and Company